---
schema_version: "secwatch.filing_event.v1"
accession: "0001161697-22-000259"
form_type: "8-K"
ticker: "KRMD"
cik: "0000704440"
company_name: "KORU Medical Systems, Inc."
filed_at: "2022-05-18T23:59:59+00:00"
generated_at: "2026-06-25T10:34:05.257274+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Repro Med CFO Karen Fisher to resign June 30, 2022; Tom Adams named interim CFO

## Summary
- CFO Karen Fisher resigns effective June 30, 2022; no disagreements with company.
- Transition Agreement includes severance per existing employment agreement and $60,000 payment.
- Tom Adams, VP of Financial Planning & Analysis since Nov 2021, will serve as interim CFO from July 1.
- Adams has 20+ years med-tech/pharma finance experience, previously at Integra Life Sciences and Pfizer.

## SEC filing metadata
- accession: 0001161697-22-000259
- form_type: 8-K
- ticker: KRMD
- cik: 0000704440
- company_name: KORU Medical Systems, Inc.
- filed_at: 2022-05-18T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/704440/000116169722000259/0001161697-22-000259-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/704440/000116169722000259/form_8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001161697-22-000259
- JSON: https://secwatch.observer/filing/0001161697-22-000259.json
- Plain text: https://secwatch.observer/filing/0001161697-22-000259.txt

## Key facts
- Executive change
  Tom Adams was appointed as Interim Chief Financial Officer at KORU Medical Systems, Inc..
  - Action: appointed
  - Role: Interim Chief Financial Officer
  source text: In the interim, the Company’s Vice President of Financial Planning and Analysis, Tom Adams, will serve as Interim Chief Financial Officer of the Company effective July 1, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/704440/000116169722000259/0001161697-22-000259-index.htm
- Executive change
  Karen Fisher departed as Chief Financial Officer at KORU Medical Systems, Inc..
  - Action: resign
  - Role: Chief Financial Officer
  source text: As reported under Item 1.01 above, Karen Fisher, the Company’s Chief Financial Officer, will resign her employment effective as of June 30, 2022 to pursue other opportunities.
  evidence_url: https://www.sec.gov/Archives/edgar/data/704440/000116169722000259/0001161697-22-000259-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.